NCT00558493View on ClinicalTrials.gov

Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 30, 2007

Conditions
Chronic Hepatitis B
Interventions
DRUG

Clevudine

clevudine 30 mg qd for 24 seeks

Trial Locations (1)

Unknown

Youngnam University Medical Center, Daegu

Sponsors
All Listed Sponsors
lead

Bukwang Pharmaceutical

INDUSTRY

NCT00558493 - Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B Patients | Biotech Hunter | Biotech Hunter